About David Bostwick
Form D filings for Triopsy Medical from 2022 to 2024 list David Bostwick as executive officer and director.
David Bostwick first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name David Bostwick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Bostwick works with at each company, as listed on that company's latest Form D.
Triopsy Medical, Inc. · Form D, Feb 28, 2024
RL
Richard Larson
Director
JL
James Lousararian
Director
Brad Buscher
Executive Chairman
JH
John Harper
Director
DW
Deborah Wittman
Director
MM
Michael Montag
Director